These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 23389245)
1. Aurora kinase inhibitor AZD1152 has an additional effect of platinum on a sequential application at the human ovarian cancer cell line SKOV3. Ma Y; Weimer J; Fredrik R; Adam-Klages S; Sebens S; Caliebe A; Hilpert F; Eckmann-Scholz C; Arnold N; Schem C Arch Gynecol Obstet; 2013 Jul; 288(1):173-82. PubMed ID: 23389245 [TBL] [Abstract][Full Text] [Related]
2. [Effect of aurora kinase B inhibitor AZD1152 in the treatment of cisplatin-resistant ovarian carcinoma]. Ma YX; Li XZ Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):46-50. PubMed ID: 23531251 [TBL] [Abstract][Full Text] [Related]
3. Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc. Ma Y; Cao H; Lou S; Shao X; Lv W; Qi X; Liu Y; Ying M; He Q; Yang X J Mol Med (Berl); 2015 Apr; 93(4):427-38. PubMed ID: 25411027 [TBL] [Abstract][Full Text] [Related]
4. Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA. Zekri A; Ghaffari SH; Yaghmaie M; Estiar MA; Alimoghaddam K; Modarressi MH; Ghavamzadeh A Mol Neurobiol; 2016 Apr; 53(3):1808-1823. PubMed ID: 25752998 [TBL] [Abstract][Full Text] [Related]
5. The topoisomerase I poison CPT-11 enhances the effect of the aurora B kinase inhibitor AZD1152 both in vitro and in vivo. Nair JS; de Stanchina E; Schwartz GK Clin Cancer Res; 2009 Mar; 15(6):2022-30. PubMed ID: 19276280 [TBL] [Abstract][Full Text] [Related]
6. Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines. Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Morrone S; Moretti C; Bononi M; Arlot-Bonnemains Y; D'Armiento M; Ulisse S Endocr Relat Cancer; 2014 Oct; 21(5):797-811. PubMed ID: 25074669 [TBL] [Abstract][Full Text] [Related]
7. Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer. Gully CP; Zhang F; Chen J; Yeung JA; Velazquez-Torres G; Wang E; Yeung SC; Lee MH Mol Cancer; 2010 Feb; 9():42. PubMed ID: 20175926 [TBL] [Abstract][Full Text] [Related]
8. Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia. Ghanizadeh-Vesali S; Zekri A; Zaker F; Zaghal A; Yousefi M; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH Ann Hematol; 2016 Jun; 95(7):1031-42. PubMed ID: 27091351 [TBL] [Abstract][Full Text] [Related]
9. Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line. Tuccilli C; Baldini E; Prinzi N; Morrone S; Sorrenti S; Filippini A; Catania A; Alessandrini S; Rendina R; Coccaro C; D'Armiento M; Ulisse S Endocrine; 2016 May; 52(2):287-95. PubMed ID: 26215279 [TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species generation and increase in mitochondrial copy number: new insight into the potential mechanism of cytotoxicity induced by aurora kinase inhibitor, AZD1152-HQPA. Zekri A; Mesbahi Y; Ghanizadeh-Vesali S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH Anticancer Drugs; 2017 Sep; 28(8):841-851. PubMed ID: 28639950 [TBL] [Abstract][Full Text] [Related]
11. AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Yang J; Ikezoe T; Nishioka C; Tasaka T; Taniguchi A; Kuwayama Y; Komatsu N; Bandobashi K; Togitani K; Koeffler HP; Taguchi H; Yokoyama A Blood; 2007 Sep; 110(6):2034-40. PubMed ID: 17495131 [TBL] [Abstract][Full Text] [Related]
12. AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947. Libertini S; Abagnale A; Passaro C; Botta G; Barbato S; Chieffi P; Portella G Endocr Relat Cancer; 2011 Feb; 18(1):129-41. PubMed ID: 21071467 [TBL] [Abstract][Full Text] [Related]
13. ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin. Zhang L; Zhang S J Obstet Gynaecol Res; 2011 Jun; 37(6):591-600. PubMed ID: 21159048 [TBL] [Abstract][Full Text] [Related]
14. Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo. Helfrich BA; Kim J; Gao D; Chan DC; Zhang Z; Tan AC; Bunn PA Mol Cancer Ther; 2016 Oct; 15(10):2314-2322. PubMed ID: 27496133 [TBL] [Abstract][Full Text] [Related]
15. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species. Yang YI; Kim JH; Lee KT; Choi JH Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308 [TBL] [Abstract][Full Text] [Related]
16. Janus face-like effects of Aurora B inhibition: antitumoral mode of action versus induction of aneuploid progeny. Wiedemuth R; Klink B; Fujiwara M; Schröck E; Tatsuka M; Schackert G; Temme A Carcinogenesis; 2016 Oct; 37(10):993-1003. PubMed ID: 27515963 [TBL] [Abstract][Full Text] [Related]
17. Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts. Walsby E; Walsh V; Pepper C; Burnett A; Mills K Haematologica; 2008 May; 93(5):662-9. PubMed ID: 18367484 [TBL] [Abstract][Full Text] [Related]
18. [Comparative study of that synergistic effect of cisplatin combined with compound herbal medicinal prescription for tonic quality and activating blood circulation is on SKOV3 cell proliferation and apoptosis]. Suo YP; Wang BY; Hong Z; Yin RT; Wang DQ; Peng ZL Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):542-6. PubMed ID: 16909597 [TBL] [Abstract][Full Text] [Related]
19. Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3. Fu S; Li Y; Huang J; Liu T; Hong Z; Chen A; Bast RC; Kavanagh JJ; Gershenson DM; Sood AK; Hu W Cancer Biol Ther; 2012 Sep; 13(11):1034-41. PubMed ID: 22895067 [TBL] [Abstract][Full Text] [Related]
20. AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Wilkinson RW; Odedra R; Heaton SP; Wedge SR; Keen NJ; Crafter C; Foster JR; Brady MC; Bigley A; Brown E; Byth KF; Barrass NC; Mundt KE; Foote KM; Heron NM; Jung FH; Mortlock AA; Boyle FT; Green S Clin Cancer Res; 2007 Jun; 13(12):3682-8. PubMed ID: 17575233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]